Invesco Pharmaceuticals ETF Rating $92.68 -0.06 (-0.06%) Closing price 09/19/2025 04:10 PM EasternExtended Trading$92.70 +0.02 (+0.02%) As of 09/19/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestBuy This Stock Invesco Pharmaceuticals ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PJP Aggregate RatingModerate Buy 2.70Holdings in PJP have an aggregate rating of Moderate Buy based on 347 analyst ratings issued in the past year covering 25 companies (86.9% of the portfolio).PJP Aggregate Price Target$92.68High Prediction$92.68Average Prediction$92.68Low Prediction$92.68Holdings in PJP have an aggregate price target of $92.68 and a range of $92.68 to $92.68 covering 25 companies (86.9% of the portfolio).PJP Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy9 Buy rating(s)Moderate Buy9 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Invesco Pharmaceuticals ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 PJP Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.03%ABBVAbbVie$222.29+0.1%4.77 of 5 stars2.93$222.68 0.2%27Trending NewsAnalyst ForecastAnalyst RevisionHigh Trading Volume4.98%JNJJohnson & Johnson$175.97+1.0%4.713 of 5 stars2.62$177.87 1.1%21Trending NewsAnalyst ForecastHigh Trading Volume4.97%LLYEli Lilly and Company$753.52-1.2%4.9971 of 5 stars2.67$939.61 24.7%24Trending NewsAnalyst ForecastHigh Trading Volume4.97%ABTAbbott Laboratories$136.22+1.2%4.9114 of 5 stars2.90$145.22 6.6%21News CoveragePositive NewsDividend AnnouncementHigh Trading Volume4.87%MRKMerck & Co., Inc.$81.41-0.1%4.9993 of 5 stars2.33$106.41 30.7%21Trending NewsAnalyst DowngradeHigh Trading Volume4.85%PFEPfizer$24.03-0.5%4.9846 of 5 stars2.39$28.12 17.0%18Positive NewsAnalyst UpgradeHigh Trading Volume4.84%GILDGilead Sciences$114.09+0.4%4.9209 of 5 stars2.89$117.17 2.7%28Positive NewsAnalyst ForecastInsider TradeHigh Trading Volume4.76%AMGNAmgen$285.41+3.5%4.562 of 5 stars2.24$304.43 6.7%21Positive NewsHigh Trading Volume3.30%UTHRUnited Therapeutics$417.57+1.9%4.6574 of 5 stars2.69$438.85 5.1%13Trending NewsInsider TradeHigh Trading Volume3.25%TVTXTravere Therapeutics$24.85+2.7%2.8071 of 5 stars2.87$34.20 37.6%15Analyst ForecastGap Up2.82%LGNDLigand Pharmaceuticals$166.51-2.0%4.2389 of 5 stars3.00$176.50 6.0%6News CoveragePositive NewsHigh Trading Volume2.82%INVAInnoviva$19.19-3.5%4.8032 of 5 stars3.00$42.75 122.8%4Positive NewsShort Interest ↓High Trading Volume2.80%ANIPANI Pharmaceuticals$96.79-0.7%4.0309 of 5 stars3.11$93.00 -3.9%9Positive NewsAnalyst ForecastAnalyst Revision2.77%OCULOcular Therapeutix$12.10-4.8%3.8815 of 5 stars3.00$17.83 47.4%6Positive News2.76%PCRXPacira BioSciences$26.66+0.0%3.286 of 5 stars2.71$30.83 15.7%7Positive NewsHigh Trading Volume2.75%SUPNSupernus Pharmaceuticals$46.04-0.2%2.7522 of 5 stars3.00$43.00 -6.6%4Analyst UpgradeHigh Trading Volume2.75%JAZZJazz Pharmaceuticals$128.30-2.2%4.4602 of 5 stars2.88$178.67 39.3%16Positive NewsHigh Trading Volume2.75%BIIBBiogen$142.50-0.9%4.6866 of 5 stars2.32$181.65 27.5%31Positive NewsAnalyst DowngradeHigh Trading Volume2.73%COLLCollegium Pharmaceutical$35.75-1.1%3.7366 of 5 stars3.00$42.33 18.4%32.73%AMRXAMNEAL PHARMACEUTICALS$9.813.3126 of 5 stars3.00$12.00 22.3%5Positive NewsAnalyst ForecastHigh Trading Volume2.71%AVDLAvadel Pharmaceuticals$16.20-0.2%2.8316 of 5 stars3.11$20.86 28.7%9Analyst Downgrade2.70%PBHPrestige Consumer Healthcare$63.11-1.5%4.2325 of 5 stars2.29$93.33 47.9%7News CoverageAnalyst Revision2.68%CORTCorcept Therapeutics$80.52+0.9%4.7776 of 5 stars3.00$135.25 68.0%5Positive NewsHigh Trading Volume2.66%VTRSViatris$9.90+0.4%1.1349 of 5 stars1.80$10.40 5.1%5High Trading Volume2.65%BMYBristol Myers Squibb$45.05-1.2%4.9275 of 5 stars2.24$56.38 25.1%21Trending NewsDividend AnnouncementAnalyst RevisionHigh Trading Volume This page (NYSEARCA:PJP) was last updated on 9/20/2025 by MarketBeat.com Staff From Our PartnersREVEALED: Something Big Happening Behind White House Doorswhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredCollege grad makes $64,000 a monthA Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took ...Stansberry Research | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredThe Coin That Could Define Trump’s Crypto PresidencyWhen Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top ad...Weiss Ratings | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Invesco Pharmaceuticals ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
